Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$27,936
+$1,048 QoQ
Shares Held
110
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4,624
of 4,664 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gould Capital, LLC holds $5,361,370 across 4 Drug Manufacturers - General names. JNJ ranks #3 (0.5% of the industry book) .
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,936 | 110 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $26,888 | 110 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $22,764 | 110 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,396 | 110 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $16,802 | 110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,242 | 110 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,908 | 110 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $17,826 | 110 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $16,077 | 110 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $17,400 | 110 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,241 | 110 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $17,132 | 110 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $18,207 | 110 | Shares | Sole | 2023-08-25 | |
| 2023-03-31 | $17,050 | 110 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $19,431 | 110 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,766 | 121 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $21,478 | 121 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $21,444 | 121 | Shares | Sole | 2022-07-21 | |
| 2021-12-31 | $67,572 | 395 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||